Literature DB >> 19384906

Osteosarcoma in the elderly over 60 years: a multicenter study by the Japanese Musculoskeletal Oncology Group.

Yoshihiro Nishida1, Kazuo Isu, Takafumi Ueda, Yutaka Nishimoto, Hiroyuki Tsuchiya, Takuro Wada, Keiji Sato, Satoshi Tsukushi, Hideshi Sugiura.   

Abstract

BACKGROUND: Few studies have described the characteristics and prognostic factors of osteosarcoma patients aged over 60 years.
METHODS: The Japanese Musculoskeletal Oncology Group (JMOG) carried out a retrospective review of patients over the age of 60 years with osteosarcoma.
RESULTS: Only 12 patients had secondary osteosarcoma, with none associated with Paget's disease. The primary disease sites were the extremities in 63% and trunk in 33%. The overall survival was 42.8% and disease-free survival was 40.8% at 5 years in the high grade group. An univariate analysis indicated that significant poor prognostic factors for overall survival were axial location, lung metastasis at initial presentation, and absence of surgical treatment. Multivariate analysis revealed that a significant poor prognostic factor for overall survival was the absence of surgical treatment. Secondary osteosarcoma did not lower the overall or the disease-free survival in any group.
CONCLUSIONS: The current study indicates that the number of osteosarcoma patients over 60 years is increasing. The number of cases with secondary osteosarcoma over 60 years is relatively small in Japan, with no patients having osteosarcomas related to Paget's disease. Although there is a predilection for axial localization, surgical treatment has a significant impact on patient's prognosis. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19384906     DOI: 10.1002/jso.21287

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

Review 1.  Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment.

Authors:  Rajendra Kumar; Meena Kumar; Kavin Malhotra; Shreyaskumar Patel
Journal:  Curr Oncol Rep       Date:  2018-02-28       Impact factor: 5.075

2.  Prognosis of Primary Osteosarcoma in Elderly Patients: A Comparison between Young and Elderly Patients.

Authors:  Hiroyuki Tsuchie; Makoto Emori; Hiroyuki Nagasawa; Naohisa Miyakoshi; Yasutaka Murahashi; Junya Shimizu; Emi Mizushima; Toshihiko Yamashita; Yoichi Shimada
Journal:  Med Princ Pract       Date:  2019-04-17       Impact factor: 1.927

3.  Survival analysis of elderly patients with osteosarcoma.

Authors:  Yoshinori Imura; Satoshi Takenaka; Shigeki Kakunaga; Takaaki Nakai; Toru Wakamatsu; Hidetatsu Outani; Takaaki Tanaka; Hironari Tamiya; Kazuya Oshima; Kenichiro Hamada; Norifumi Naka; Nobuhito Araki; Ikuo Kudawara; Takafumi Ueda; Hideki Yoshikawa
Journal:  Int Orthop       Date:  2019-04-22       Impact factor: 3.075

4.  Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional study.

Authors:  Eiji Kozawa; Yoshihiro Nishida; Akira Kawai; Keiko Hayakawa; Nokitaka Setsu; Hiroyuki Kawashima; Shintaro Iwata; Hiroyuki Tsuchiya; Satoshi Tsukushi; Satoshi Takenaka; Jungo Imanishi; Ichiro Baba; Akihito Nagano; Takeshi Morii; Toshiharu Shirai; Koki Shimizu; Hirotaka Kawano
Journal:  Cancer Sci       Date:  2022-05-18       Impact factor: 6.518

5.  Neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patients.

Authors:  Hiroshi Urakawa; Satoshi Tsukushi; Hideshi Sugiura; Kenji Yamada; Yoshihisa Yamada; Eiji Kozawa; Eisuke Arai; Naohisa Futamura; Naoki Ishiguro; Yoshihiro Nishida
Journal:  Oncol Lett       Date:  2014-09-26       Impact factor: 2.967

6.  The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.

Authors:  Yusuke Tsuda; Koichi Ogura; Yusuke Shinoda; Hiroshi Kobayashi; Sakae Tanaka; Akira Kawai
Journal:  BMC Cancer       Date:  2018-05-31       Impact factor: 4.430

7.  Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database.

Authors:  Yue Pan; Daqi Chen; Taobo Hu; Guohua Lv; Zhehao Dai
Journal:  Cancer Control       Date:  2019 Jan-Dec       Impact factor: 3.302

8.  Metastasis of osteosarcoma to stomach made clinically evident by hematemesis: a case report.

Authors:  Hiroshi Urakawa; Satoshi Tsukushi; Issei Tsurudome; Akihiro Hirata; Eisuke Arai; Eiji Kozawa; Naohisa Futamura; Ryoji Miyahara; Naoki Ishiguro; Yoshihiro Nishida
Journal:  World J Surg Oncol       Date:  2013-02-26       Impact factor: 2.754

9.  Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.

Authors:  Shinji Miwa; Akihiko Takeuchi; Toshiharu Shirai; Junichi Taki; Norio Yamamoto; Hideji Nishida; Katsuhiro Hayashi; Yoshikazu Tanzawa; Hiroaki Kimura; Kentaro Igarashi; Akishi Ooi; Hiroyuki Tsuchiya
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

10.  Prognostic factors in osteosarcoma: A study level meta-analysis and systematic review of current practice.

Authors:  Sun Xin; Guo Wei
Journal:  J Bone Oncol       Date:  2020-02-21       Impact factor: 4.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.